About 140 million Americans, more than half of the nation’s adults, could be considered candidates for weight loss drugs Ozempic and Wegovy, according to a new study from JAMA Cardiology. NBC medical contributor Dr. Natalie Azar breaks down the latest for TODAY. NBC News Health
About 140 million Americans, more than half of the nation’s adults, could be considered candidates for weight loss drugs Ozempic and Wegovy, according to a new study from JAMA Cardiology. NBC medical contributor Dr. Natalie Azar breaks down the latest for TODAY.
